Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Hims & Hers’ Compounded Semaglutide Pill Triggers US FDA Enforcement
Feb 06 2026
•
By
Sue Sutter
Hims & Hers is facing a DoJ investigation for semaglutide compounding.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Compliance
More from United States